Answers are grounded in this paper and cite their sources.
Narrative review highlights challenges in efficient research and innovation for healthcare in low and middle-income countries.
In recent decades, medical science production has increased significantly. Cellular and molecular mechanisms of many diseases were discovered. However, the quantity of treatments and other healthcare-related technologies has not progressed significantly. As a result, translational medicine, a research approach that links bench to bedside and community, was introduced. Nevertheless, the aforementioned approach was not efficient enough to improve healthcare in a timely manner. So, translational medicine was established to discover and address prohibitory issues of translational medicine. Nevertheless, the development of translational medicine in low and middle-income countries faces numerous challenges that need to be resolved. The aim of this narrative review is to describe the recent development of translational medicine in the world and its challenges in low and middle-income countries.
No takes yet. Share an insight, caveat, or question.
Dabbagh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: